Search Results
Dec 10, 2025, 10:00 ET HIRO Capital welcomes Sir Nick Clegg as General Partner and launches HIRO III European scaleup VC fund with new Advisory Board of global leaders including Yann LeCun
multi-stage fund able to deploy from €5m-€50m each into promising innovators, targeting the scale-up capital gap in the UK and Europe.The HIRO founding GP team of Luke Alvarez, Cherry Freeman and UK games legend Sir Ian Livingstone CBE have strong pedigree as founder-entrepreneurs, with multiple exits and
More news about: HIRO Capital
Dec 09, 2025, 07:30 ET Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
use with moderate CYP3A inducers is unavoidable, increase Jaypirca dose according to approved labeling.Sensitive CYP2C8, CYP2C19, CYP3A, P-gp, or BCRP Substrates: Use with Jaypirca increased their plasma concentrations, which may increase risk of ARs related to these substrates for drugs
More news about: Eli Lilly and Company
Dec 08, 2025, 18:30 ET Club Med Expands Brand Presence in Canada with the Announcement of Club Med Tremblant
nature.About Alderan Alderan is an independent French portfolio management company, founded in 2015 by Rémy Bourgeon and approved by the AMF in 2017 under license number GP-17000026. Alderan manages, on behalf of six regulated funds intended for non-professional clients (SCPI) and professional clients (Professional OPCIs and
More news about: Club Med
Dec 08, 2025, 11:30 ET MJFF Initiates Funding for Emerging Therapeutic Targets in Parkinson's Disease
including the Collaborative Research Network (CRN), the Parkinson's Progression Markers Initiative (PPMI) and the Global Parkinson's Genetics Program (GP2). This process yielded 21 priority targets and their pathways, which now guide MJFF's near-term validation efforts and form the foundation of the program's
More news about: The Michael J. Fox Foundation for Parkinson's Research
Dec 08, 2025, 10:00 ET Splitero, Funds Managed by Blue Owl, and Antarctica Capital Close $283.3 Million Home Equity Investment Inaugural Securitization
With over $295 billion in assets under management as of September 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer
More news about: Splitero
Dec 07, 2025, 16:30 ET Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
use with moderate CYP3A inducers is unavoidable, increase Jaypirca dose according to approved labeling.Sensitive CYP2C8, CYP2C19, CYP3A, P-gp, or BCRP Substrates: Use with Jaypirca increased their plasma concentrations, which may increase risk of ARs related to these substrates for drugs
More news about: Eli Lilly and Company
Dec 05, 2025, 09:00 ET Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting
CYP2C19 may affect EPIDIOLEX exposure. EPIDIOLEX may affect exposure to CYP2C19 substrates (e.g., clobazam, diazepam, stiripentol), orally administered P-gp substrates, or other substrates (see full Prescribing Information). Consider dose reduction of orally administered everolimus, with appropriate therapeutic
More news about: Jazz Pharmaceuticals plc
Dec 05, 2025, 08:00 ET Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting
(2%).Drug Interactions Combined P-gp and Strong CYP3A Inducers Concomitant use of XOSPATA with a combined P-gp and strong CYP3A inducer decreases XOSPATA exposure which may decrease XOSPATA efficacy. Avoid concomitant use of XOSPATA with combined P-gp and strong CYP3A inducers.Strong
More news about: Astellas Pharma Inc.
Dec 03, 2025, 17:31 ET Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight
11.9ESPEROCT (N8-GP; Turoctocog alfa pegol): Novo Nordisk11.10
More news about: DelveInsight Business Research, LLP
Dec 03, 2025, 12:59 ET U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor
use with moderate CYP3A inducers is unavoidable, increase Jaypirca dose according to approved labeling.Sensitive CYP2C8, CYP2C19, CYP3A, P-gp, or BCRP Substrates: Use with Jaypirca increased their plasma concentrations, which may increase risk of ARs related to these substrates for drugs
More news about: Eli Lilly and Company
Dec 03, 2025, 12:07 ET Lawsuit Claims Unsafe Discipline at Rockwall School Led to 3-Year-Old's Emergency Airlift
individually and as parents and next friends of L.S., a minor child, vs. Galaxy Ranch School, LP d/b/a Galaxy Ranch Private School; and Galaxy Ranch GP, LLC d/b/a Galaxy Ranch Private School, Cause No. DC-25-22164 in the District Court of Dallas County, Texas. A copy of the complaint can be accessed
More news about: The Button Law Firm
Dec 03, 2025, 10:00 ET VELO & THE McLAREN FORMULA 1® TEAM UNVEIL ABU DHABI GP LIVERY INSPIRED BY FANS' FAVOURITE McLAREN MEMORIES
multimedia:https://www.prnewswire.co.uk/news-releases/velo--the-mclaren-formula-1-team-unveil-abu-dhabi-gp-livery-inspired-by-fans-favourite-mclaren-memories-302631879.html
More news about: VELO
Dec 02, 2025, 11:52 ET Why CoVet Is Not Building a Practice Management System, and Why That Is Good for Veterinary Medicine
seeking out dedicated assistants even when their PMS has a built-in offering. A general AI tool simply cannot adapt to the personal style of a GP, let alone the highly specific terminology of a specialist, forcing them to find a workaround. This leads to a fragmented user experience and tools that
More news about: CoVet
Dec 02, 2025, 10:24 ET El título de la F1 se decidirá en el Gran Premio de Abu Dabi 2025
Elba, Keinemusik y Calvin Harris como cabezas de cartel.Los aficionados pueden comenzar su recorrido durante la semana de la carrera en la app del GP de Abu Dabi, la plataforma central para entradas, reservas de Pit Lane Walk, programación, señalización digital y alertas en tiempo real. La app está
More news about: Abu Dhabi Grand Prix
Dec 02, 2025, 08:00 ET Anderson Global acquires Woodside Corporate Services Limited and its parent entities
https://anderson-global.com/About Kin GroupKin offer a variety of services to Venture Capital firms, including Fund Management offerings to GP/LPs, ECFs, SPVs, EIS and SEIS funds and a range of Regulatory Umbrella Services through appointed representative and secondment arrangements to reduce regulatory
More news about: Anderson Global
Dec 02, 2025, 07:00 ET Dechert Finds GPs Unlocking Liquidity to Power Investor Opportunity Amid a Gradual Market Thaw
companies.Fundraising: 64% of respondents are expanding into additional investment strategies to mitigate fundraising pressures.GP-led secondaries: 46% of respondents are utilizing GP-led secondaries or continuation vehicles to facilitate distributions to existing LPs and mitigate potential fundraising challenges
More news about: Dechert LLP
Dec 01, 2025, 14:26 ET F1-TITEL WIRD BEIM GROSSEN PREIS VON ABU DHABI 2025 ENTSCHIEDEN
offizielle After-Partys mit Idris Elba, Keinemusik und Calvin Harris vorsieht.Die Fans können ihre Reise durch die Rennwoche mit der Abu Dhabi GP-App beginnen, der zentralen Anlaufstelle für Tickets, Buchungen für den Pit Lane Walk, den Programmplan, die digitale Wegbeschreibung und Echtzeit-Warnungen.
More news about: Abu Dhabi Grand Prix
Dec 01, 2025, 14:22 ET LE TITRE DE CHAMPION DE F1 SE JOUERA AU GRAND PRIX D'ABU DHABI 2025
Idris Elba, Keinemusik et Calvin Harris en tête d'affiche.Les fans peuvent commencer leur périple de la semaine de course sur l'application du GP d'Abu Dhabi, le centre central pour les billets, les réservations de la Pit Lane Walk, le programme, l'orientation numérique et les alertes en temps
More news about: Abu Dhabi Grand Prix
Dec 01, 2025, 13:41 ET F1 TITLE TO BE DECIDED AT 2025 ABU DHABI GRAND PRIX
along with Official After-Parties headlined by Idris Elba, Keinemusik and Calvin Harris.Fans can start their race week journey on the Abu Dhabi GP app, the central hub for tickets, Pit Lane Walk bookings, programme schedule, digital wayfinding and real-time alerts. The app is available on the Apple
More news about: Abu Dhabi Grand Prix
Dec 01, 2025, 13:34 ET F1 TITLE TO BE DECIDED AT 2025 ABU DHABI GRAND PRIX
along with Official After-Parties headlined by Idris Elba, Keinemusik and Calvin Harris.Fans can start their race week journey on the Abu Dhabi GP app, the central hub for tickets, Pit Lane Walk bookings, programme schedule, digital wayfinding and real-time alerts. The app is available on the Apple
More news about: Abu Dhabi Grand Prix
Dec 01, 2025, 09:00 ET 100,000 Participants and Counting: Massive Global Genetic Dataset Powers Discoveries in Parkinson's Disease
early efforts to expand outreach to underrepresented communities, the unprecedented scale of GP2 and the resource it is creating is transformational."GP2's approach is already yielding results. In 2023, GP2 investigators identified a new risk variant linked to Parkinson's disease for individuals
More news about: Aligning Science Across Parkinson's
Nov 28, 2025, 08:34 ET Latvian Delegation's Visit to the UAE Delivers Breakthrough in Economic and Business Cooperation
Fund.Participating Latvian companies and organisations:3D Engineering, AJ Power, Alūksnes Putnu Fabrika, AmCraft, Asya, BSC Group, GP Systems, HMP Group, IT Camp, LAMOD, Latvian Employers' Confederation, Latvian Chamber of Commerce and Industry, Primekss, Freeport of Riga Authority,
More news about: The Investment and Development Agency of Latvia (Latvijas Investīciju un attīstības aģentūra)
Nov 26, 2025, 08:00 ET Blue Owl Capital Inc. to Present at the Goldman Sachs 2025 US Financial Services Conference
alternatives®.With over $295 billion in assets under management as of September 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer
More news about: Blue Owl Capital
Nov 24, 2025, 16:30 ET Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium
use cannot be avoided, increase the dosage of Inluriyo.Imlunestrant inhibits both P-gp and BCRP. Avoid concomitant use unless otherwise recommended in the Prescribing Information for P-gp or BCRP substrates where minimal concentration changes may lead to serious adverse reactions.Use
More news about: Eli Lilly and Company
Nov 24, 2025, 12:00 ET Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting
use with moderate CYP3A inducers is unavoidable, increase Jaypirca dosage according to approved labeling. Sensitive CYP2C8, CYP2C19, CYP3A, P-gp, or BCRP Substrates: Concomitant use with Jaypirca increased their plasma concentrations, which may increase risk of adverse reactions related to
More news about: Eli Lilly and Company